Connect with us

Business

New York spending $200 million on marijuana social equity properties

Published

on

New York is set to inject $200 million into the local marijuana real estate market, leasing up to 150 retail properties that will be given to social equity businesses to give them a leg up in the state’s new recreational market.

The move is believed to be the first of its kind in the U.S. cannabis industry, and, if successful, could provide a road map for other states rolling out social equity programs.

At least one brokerage firm, CBRE Group, is already scouting locations on behalf of the Dormitory Authority of the State of New York (DASNY), the agency overseeing the disbursement of the funds, a DASNY spokesperson confirmed in an email to MJBizDaily.

CBRE representatives are “looking for good retail locations throughout the state located in municipalities that have opted in to allow retail dispensaries,” according to the spokesperson, Jeffrey Gordon.

The brokerage firm declined to comment.

Ripple effects

While the DASNY said that no leases have been signed for social equity companies, industry insiders say the government’s entrance into marijuana real estate is causing ripple effects for other businesses – particularly smaller operators.

“They’re out there. They’re pounding the pavement,” Donny Moskovic, a real estate broker at Katz & Associates in New York City, said of CBRE agents.

Moskovic has been working with Cresco Labs – one of the state’s 10 existing medical marijuana licensees – to expand the Chicago-based multistate operator’s retail footprint in anticipation of the adult-use market’s launch.

Moskovic said there’s been a “frenzy” in the New York real estate market this year as entrepreneurs prep for the recreational market’s rollout, which could happen later this year.

“They’re everywhere. They’re looking at all locations,” Moskovic said when asked where CBRE is looking for retail spots.

He said CBRE is almost certainly already looking in every municipality that didn’t already opt out of legal cannabis sales, including New York City as well as upstate.

“If you speak to their broker, their broker tells you there’s $50 million in a fund, sitting there, already out of the $200 million, and they’re executing deals.”

The real estate support for social equity applicants has drawn praise for New York’s progressive approach to promoting diversity and increasing business opportunities for those affected by the nation’s war on drugs.

But it also has triggered concerns among local entrepreneurs and real estate brokers, some of whom contend that real estate agents working on behalf of the state might increase competition – and prices – for smaller operators also hunting for retail properties.

“It’s making it more competitive for the industry as a whole,” said Colby Piper, a New Jersey-based real estate broker who specializes in marijuana.

Piper, who’s been scouting locations for clients wanting to start adult-use companies in New York, noted the state hasn’t yet announced whether there will be mandatory setbacks between retail shops.

Mandatory setbacks make it hard for his clients to enter into long-term leases.

In addition, landlords often favor long-term deals with the state over leases with private businesses because the state is viewed as a more reliable a tenant, Piper said.

As a result, Piper is trying to steer clear of wherever he hears CBRE agents are scouting.

“When we find out, very quietly, where the state is looking, we can tell (our client), ‘This section might be too crowded; we should try the next block up,’” Piper said.

Program details

According to DASNY’s Gordon, the state’s fund hasn’t yet been allocated, nor has a manager for the $200 million been chosen.

He added that a pair of requests for proposals (RFPs) tied to the fund are on schedule:

  • Choosing a firm to select locations and sign tenant agreements – to be completed no earlier than June 20.
  • Picking a build-out firm to oversee construction at the leased locations – to be chosen July 11.

The money is also being spent solely for retail business locations, not for cultivators or other sectors, Gordon confirmed.

The properties will be leased for 10-year terms, with no actual purchases in the pipeline.

Gordon wrote that DASNY’s goal is to have the first social equity retailer open by the end of the year and to have all 150 locations identified by the end of the second quarter of 2023.

Unanswered questions

Several questions remain, including how successful DASNY will be in trying to lock down 150 retail locations in New York for 10 years with only a $200 million budget.

According to a May 13 news release, the $200 million will come from “licensing fees and revenue from the adult-use cannabis industry and up to $150 million from the private sector,” not from the state general fund.

“Depending on how they negotiate these deals, and when the actual rent triggers, it could be possible” to get 150 locations rented, Piper said.

“But if the rent triggers Day One or Month Two, and they’re paying rent before they have applications written or before the application window even opens, that money is going to burn down pretty quickly.”

Many retail locations rent for as much as $45,000 per month, Piper noted as a hypothetical example.

“If you’re paying $45,000 a month, that doesn’t give you many locations” with $200 million, Piper said.

There’s also a lack of clarity around the licensing process and the social equity program in general, stakeholders said.

So far, the state hasn’t announced how many adult-use licenses will be issued, although regulators have said that half the permits will be reserved for social equity applicants.

It’s also unclear when the licensing window will open, either for social equity companies or non-social equity businesses.

Furthermore, many entrepreneurs are awaiting the final state marijuana industry regulations.

Many believe they can’t make solid plans without first knowing the regulatory framework, Piper said.

“They’re writing the regulations in piecemeal,” Piper said.

“The people who are trying to secure space (for marijuana businesses) … are not able to get ahead of the game with a risk-averse strategy without having the regulations,” he said.

“If we’re looking at five spaces with an operator, and the regs come out and say you have to be a thousand feet from a church, then maybe those five locations won’t be there. We don’t know.”

However, Moskovic added that the New York real estate market is large enough that DASNY and CBRE’s efforts have not been a major disruptor for dealmakers like him. He also predicted it won’t be an issue for larger businesses.

Rather, it’ll likely be more problematic for smaller- to medium-sized companies that are looking at retail spaces that might suit social equity startups, Moskovic said.

By contrast, Moskovic hasn’t run into major issues helping Cresco Labs find real estate for its expansion plans.

“At the end of the day, there’s a lot of real estate out there,” Moskovic said.

Source: https://mjbizdaily.com/new-york-spending-200-million-on-marijuana-social-equity-properties/

Business

New Mexico cannabis operator fined, loses license for alleged BioTrack fraud

Published

on

New Mexico regulators fined a cannabis operator nearly $300,000 and revoked its license after the company allegedly created fake reports in the state’s traceability software.

The New Mexico Cannabis Control Division (CCD) accused marijuana manufacturer and retailer Golden Roots of 11 violations, according to Albuquerque Business First.

Golden Roots operates the The Cannabis Revolution Dispensary.

The majority of the violations are related to the Albuquerque company’s improper use of BioTrack, which has been New Mexico’s track-and-trace vendor since 2015.

The CCD alleges Golden Roots reported marijuana production only two months after it had received its vertically integrated license, according to Albuquerque Business First.

Because cannabis takes longer than two months to be cultivated, the CCD was suspicious of the report.

After inspecting the company’s premises, the CCD alleged Golden Roots reported cultivation, transportation and sales in BioTrack but wasn’t able to provide officers who inspected the site evidence that the operator was cultivating cannabis.

In April, the CCD revoked Golden Roots’ license and issued a $10,000 fine, according to the news outlet.

The company requested a hearing, which the regulator scheduled for Sept. 1.

At the hearing, the CCD testified that the company’s dried-cannabis weights in BioTrack were suspicious because they didn’t seem to accurately reflect how much weight marijuana loses as it dries.

Company employees also poorly accounted for why they were making adjustments in the system of up to 24 pounds of cannabis, making comments such as “bad” or “mistake” in the software, Albuquerque Business First reported.

Golden Roots was fined $298,972.05 – the amount regulators allege the company made selling products that weren’t properly accounted for in BioTrack.

The CCD has been cracking down on cannabis operators accused of selling products procured from out-of-state or not grown legally:

Golden Roots was the first alleged rulebreaker in New Mexico to be asked to pay a large fine.

Source: https://mjbizdaily.com/new-mexico-cannabis-operator-fined-loses-license-for-alleged-biotrack-fraud/

Continue Reading

Business

Marijuana companies suing US attorney general in federal prohibition challenge

Published

on

Four marijuana companies, including a multistate operator, have filed a lawsuit against U.S. Attorney General Merrick Garland in which they allege the federal MJ prohibition under the Controlled Substances Act is no longer constitutional.

According to the complaint, filed Thursday in U.S. District Court in Massachusetts, retailer Canna Provisions, Treevit delivery service CEO Gyasi Sellers, cultivator Wiseacre Farm and MSO Verano Holdings Corp. are all harmed by “the federal government’s unconstitutional ban on cultivating, manufacturing, distributing, or possessing intrastate marijuana.”

Verano is headquartered in Chicago but has operations in Massachusetts; the other three operators are based in Massachusetts.

The lawsuit seeks a ruling that the “Controlled Substances Act is unconstitutional as applied to the intrastate cultivation, manufacture, possession, and distribution of marijuana pursuant to state law.”

The companies want the case to go before the U.S. Supreme Court.

They hired prominent law firm Boies Schiller Flexner to represent them.

The New York-based firm’s principal is David Boies, whose former clients include Microsoft, former presidential candidate Al Gore and Elizabeth Holmes’ disgraced startup Theranos.

Similar challenges to the federal Controlled Substances Act (CSA) have failed.

One such challenge led to a landmark Supreme Court decision in 2005.

In Gonzalez vs. Raich, the highest court in the United States ruled in a 6-3 decision that the commerce clause of the U.S. Constitution gave Congress the power to outlaw marijuana federally, even though state laws allow the cultivation and sale of cannabis.

In the 18 years since that ruling, 23 states and the District of Columbia have legalized adult-use marijuana and the federal government has allowed a multibillion-dollar cannabis industry to thrive.

Since both Congress and the U.S. Department of Justice, currently headed by Garland, have declined to intervene in state-licensed marijuana markets, the key facts that led to the Supreme Court’s 2005 ruling “no longer apply,” Boies said in a statement Thursday.

“The Supreme Court has since made clear that the federal government lacks the authority to regulate purely intrastate commerce,” Boies said.

“Moreover, the facts on which those precedents are based are no longer true.”

Verano President Darren Weiss said in a statement the company is “prepared to bring this case all the way to the Supreme Court in order to align federal law with how Congress has acted for years.”

While the Biden administration’s push to reschedule marijuana would help solve marijuana operators’ federal tax woes, neither rescheduling nor modest Congressional reforms such as the SAFER Banking Act “solve the fundamental issue,” Weiss added.

“The application of the CSA to lawful state-run cannabis business is an unconstitutional overreach on state sovereignty that has led to decades of harm, failed businesses, lost jobs, and unsafe working conditions.”

Source: https://mjbizdaily.com/marijuana-companies-suing-us-attorney-general-to-overturn-federal-prohibition/

Continue Reading

Business

Alabama to make another attempt Dec. 1 to award medical cannabis licenses

Published

on

Alabama regulators are targeting Dec. 1 to award the first batch of medical cannabis business licenses after the agency’s first two attempts were scrapped because of scoring errors and litigation.

The first licenses will be awarded to individual cultivators, delivery providers, processors, dispensaries and state testing labs, according to the Alabama Medical Cannabis Commission (AMCC).

Then, on Dec. 12, the AMCC will award licenses for vertically integrated operations, a designation set primarily for multistate operators.

Licenses are expected to be handed out 28 days after they have been awarded, so MMJ production could begin in early January, according to the Alabama Daily News.

That means MMJ products could be available for patients around early March, an AMCC spokesperson told the media outlet.

Regulators initially awarded 21 business licenses in June, only to void them after applicants alleged inconsistencies with how the applications were scored.

Then, in August, the state awarded 24 different licenses – 19 went to June recipients – only to reverse themselves again and scratch those licenses after spurned applicants filed lawsuits.

A state judge dismissed a lawsuit filed by Chicago-based MSO Verano Holdings Corp., but another lawsuit is pending.

Source: https://mjbizdaily.com/alabama-plans-to-award-medical-cannabis-licenses-dec-1/

Continue Reading

Trending

Copyright © 2022 420 Reports Marijuana News & Information Website | Reefer News | Cannabis News